Introduction
In its common form miliary tuberculosis is a disease of young children, usually occurring within a few months of the primary infection (Miller, Seal, and Taylor, 1963) . It may also be a terminal event in other forms of tuberculosis. Though predominantly a disease of the young, a considerable number of cases arising in patients over the age of 60 years has been described (Braun, 1917; Hartwich, 1922) .
With modem public health measures, including mass miniature radiography, particularly of high-risk groups, B.C.G. vaccination, and effective chemotherapy for active disease, the reservoir of tuberculous infection in many countries has diminished considerably. The incidence of classical miliary tuberculosis has fallen simultaneously and this disease is now rare even in the age group that was formerly most susceptible. Over recent years disturbing reports have been published of the diagnosis of disseminated tuberculosis being made at necropsy, the disease not having been suspected during life (Treip and Meyers, 1959; Bdttiger, Nordenstam, and Wester, 1962; Oswald, 1963; Brunner and Haemmerli, 1964) . This type of tuberculosis which we shall refer to as " cryptic " does not present the clinical and radiographic features associated with classical miliary tuberculosis.
The object of this paper is to present our experience of this type of tuberculosis with a view to increasing awareness of its existence. These patients will be compared with others suffering from classical or overt miliary tuberculosis in order to emphasize that they constitute a separate clinical entity. 
Clinical Features
The sex and age distribution in both groups is shown in Table I . 
Haematological Findings
The specific blood disorders found in the series are shown in Table III . There was no difference in the incidence of In the cryptic group disseminated tuberculosis was first diagnosed at necropsy in three cases. Only in one of these was the correct diagnosis suspected before death. In 10 other patients the diagnosis of cryptic disseminated tuberculosis was made on the response to a therapeutic trial with para-aminosalicylic acid (PAS) and isoniazid.
Tubercle bacilli were ultimately cultured from the sputum or urine of five patients in the cryptic group.
Results of Treatment A total of 30 patients (75%) survived. The mortality was the same in both groups (25%). Two patients in each group died untreated. Only one of these was suspected of having tuberculosis before death. The advanced ages of the patients and the short duration of antituberculosis therapy in those treated before death is apparent from (Hartwich, 1922; Chapman and Whorton, 1946; Biehl, 1958) (Barrett-Connor, 1967) , the majority of the very elderly in this series are likely to have been infected early in life. Nevertheless, the allergic response to the tubercle bacillus, as measured by skin tuberculin sensitivity, declines after the age of 50 years (Johnston, Ritchie, and Murray, 1963) Pancytopenia complicating tuberculosis has been reported by Fountain (1954) , Medd and Hayhoe (1955) , and Dawborn and Cowling (1961) and more recently in association with disseminated atypical mycobacterial infection (Zamorano and Tompsett, 1968) . Leukaemoid reactions (Twomey and Leavell, 1965), myelofibrosis (Crail, Alt, and Nadler, 1948) , and polycythaemia (Fitzpatrick and Schwartz, 1949; Guild and Robson, 1950) The 68 cases of miliary tuberculosis reported by Biehl (1958) were mainly of the overt type; no unusual blood disorders were found. Successful treatment of tuberculosis had no effect on the blood picture of those patients with pancytopenia (Oswald, 1963) , myeloproliferative disorders, and others with leukaemia and tuberculosis (Corr et al., 1964 (Iversen and Ofstad, 1960; Bottiger et al., 1962) . The simultaneous use of antituberculosis drugs when treating pancytopenia, leukaemia, and other blood dyscrasias has therefore been advocated (Medd and Hayhoe, 1955; Rosenthal, 1956; Skarberg, Lagerlof, and Reizenstein, 1967) .
In the present series as many as 10 of the 16 patients with cryptic disseminated tuberculosis presented with pyrexia of unknown origin as the diagnostic problem. No cause may be found despite prolonged and intensive hospital investigations, but such a problem, particularly if it arises in an elderly woman or in association with a blood dyscrasia, should alert the physician to the possibility of cryptic disseminated tuberculosis.
The importance of tuberculosis, particularly disseminated tuberculosis, as a cause of fever of unknown origin has been emphasized (B6ttiger, 1957; Petersdorf and Beeson, 1961; Bdttiger et al., 1962) . eosinophilia of 76% as the only manifestation of hypersensitivity to PAS. Miliary Tuberculosis-Paoudfoot a!.
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The problem of making a firm diagnosis remains once the suspicion has been raised. The absence of typical clinical and radiographic features has already been discussed. In the early stages and even later the tuberculin test may be misleading. Brunner and Haemmerli (1964) showed that liver biopsy was a valuable diagnostic investigation in miliary tuberculosis, with positive biopsies in 75% of 163 cases collected from the literature. In the present series liver biopsy was attempted in three patients with cryptic miliary tuberculosis and gave the diagnosis in one only.
Histological examination of bone marrow and culture for tubercle bacilli has been shown to increase the number of diagnoses in miliary tuberculosis in children (Emery and Gibbs, 1954) ; in only one out of four overt and three cryptic cases in our series was a positive culture obtained.
When all investigations fail to determine the cause of pyrexia the only method by which a diagnosis of cryptic miliary tuberculosis can be proved or refuted during life is to observe the response to a therapeutic trial with PAS and isoniazid. Streptomycin is not given because it would influence other bacterial infections. The clinical features in these cases are so striking in their seriousness that when improvement on chemotherapy takes place there is no doubt about its occurrence.
The criteria by which progress during antituberculosis therapy is assessed are of paramount importance. In 6 out of 10 patients diagnosed by means of a therapeutic trial the temperature fell to normal within a week of starting treatment. Improved well-being was usually obvious within two to six weeks, when gain in weight also became apparent. An important rise in haemoglobin was usually demonstrable within four to six weeks. Petersdorf and Beeson (1961) also found the response to antituberculosis drugs a useful diagnostic test in cases of pyrexia of unknown origin. They concluded that " when the condition of the patient will not allow liver biopsy to be done, or if this and other diagnostic manceuvres fail, a therapeutic trial with antituberculous drugs is indicated." Such a trial was also advocated by Cleve, Young, and VicenteMastellari (1957) . We wholeheartedly support this view.
Introduction
Osteomalacia and rickets are seen in two main types of acidotic renal disease, which were effectively separated by Albright and Reifenstein (1948) . In the first type (renal tubular acidosis) the metabolic acidosis is due to the tubular acidifying defect and is not associated with general (glomerular) renal failure. This type of renal osteomalacia is characterized by severe hypophosphataemia.
The second type of renal osteomalacia is that which occurs in some cases of general renal failure. This bone disease forms part of the spectrum that Stanbury (1967 Stanbury ( , 1968 ) calls azotaemic
